People
Thomas Holm Pedersen
NMD Pharma’s co-founder and CEO since 2015. His skeletal-muscle electrophysiology and ClC-1 ion-channel research at Aarhus University underpins its therapeutic platform. He holds an Aarhus doctorate and completed postdoctoral research at Cambridge.
Roles
NMD Pharma
CurrentChief Executive Officer
NMD Pharma
CurrentBoard Member
NMD Pharma
CurrentCo-founder (published founding scientist; no current executive role inferred)